All In Biotech

Drug Trial Radar · NCT00369096

Efficacy Study of the Addition of Bemiparin to Icodextrin Solution in Peritoneal Dialysis Patients (Bemidextrina)

Randomized, Controlled and Open Study to Assess the Efficacy (Peritoneal Biocompatibility) of the Addition of Bemiparin to Icodextrin Solution in Patients in Peritoneal Dialysis With Peritoneal Transport Disorders

Last checked: Nov 20, 2026Latest source record: May 14, 2010 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

76

Planned (sponsor's estimate)

Start

Sep 2006

Primary completion

Nov 2008

Study completion May 2009

Sponsor

Lead sponsor
Fundación Renal Iñigo Alvarez De ToledoAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
Infociencia S.L
First posted
Aug 29, 2006

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate whether addition of bemiparin, once daily in icodextrin solution for peritoneal dialysis for 16 weeks, increases the peritoneal capacity for ultrafiltration and/or reduces creatinine transport in peritoneal dialysis patients presenting functional disorders related to ultrafiltration deficit and/or high transport.

Conditions

  • Peritoneal Diseases

Interventions

  • bemiparin 3500 IU/dayDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Efficacy: Peritoneal function defined according to the standardized ultrafiltration capacity and/or estimated peritoneal creatinine transport estimated by D/P and mass transfer coefficient during randomized treatment

Locations

17 sites in 1 country. Site status is shown where the registry gives one.

  • Hospital Juan Canajelo

    A Coruña, Spain

  • Hospital Universitario Príncipe de Asturias

    Alcala de Henares (Madrid), Spain

  • Hospital German Trias i Pujol

    Badalona (Barcelona), Spain

  • Hospital de Bellvitge

    Barcelona, Spain

  • Hospital Arnau de Vilanova

    Lleida, Spain

  • Hospital Universitario La Princesa

    Madrid, Spain

  • Hospital Gregorio Marañón

    Madrid, Spain

  • Hospital Universitario Ramón y Cajal

    Madrid, Spain

  • Hospital Universitario La Paz

    Madrid, Spain

  • Fundación Hospital Alcorcón

    Madrid, Spain

  • Hospital Regional Universitario Carlos Haya

    Málaga, Andalusia, Spain

  • Hospital Vall d'Hebron

    Barcelona, Barcelona, Spain

  • Corporación Sanitaria Parc Tauli

    Sabadell, Barcelona, Spain

  • Hospital Clinic de Barcelona

    Barcelona, Catalonia, Spain

  • Hospital Dr. Josep Trueta

    Girona, Catalonia, Spain

  • Hospital de Orense

    Ourense, Galicia, Spain

  • Complejo hospitalario de Jaen

    Jaén, Jaen, Spain

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.